购物车
- 全部删除
- 您的购物车当前为空
Anti-Siglec-2/CD22 Antibody (2E388) 是一种 Rabbit 抗体,靶向 Siglec-2/CD22。Anti-Siglec-2/CD22 Antibody (2E388) 可用于 FCM。
Anti-Siglec-2/CD22 Antibody (2E388) 是一种 Rabbit 抗体,靶向 Siglec-2/CD22。Anti-Siglec-2/CD22 Antibody (2E388) 可用于 FCM。
产品描述 | Anti-Siglec-2/CD22 Antibody (2E388) is a Rabbit antibody targeting Siglec-2/CD22. Anti-Siglec-2/CD22 Antibody (2E388) can be used in FCM. |
Ig Type | Monoclonal Rabbit IgG |
克隆号 | 2E388 |
交叉反应 | Mouse |
验证活性 | Flow cytometric analysis of Mouse CD22 expression on BABL/c splenocytes. Cells were stained with purified anti-Mouse CD22, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. |
应用 | FCM |
推荐剂量 | FCM: 1:25-1:100 |
抗体种类 | Monoclonal |
宿主来源 | Rabbit |
构建方式 | This antibody was obtained from a rabbit immunized with purified, recombinant Mouse CD22 (rM CD22; TMPY-04083; BAE33829.1; Met1-Arg708). |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | CD22 is a member of the immunoglobulin superfamily, SIGLEC family of lectins. It is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. CD22 serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. In addition to its potential role as a mediator of intercellular interactions, signal transduction through CD22 can activate B cells and modulate antigen receptor signaling in vitro. The phenotype of CD22-deficient mice suggests that CD22 is primarily involved in the generation of mature B cells within the bone marrow, blood, and marginal zones of lymphoid tissues. CD22 recruits the tyrosine phosphatase Src homology 2 domain-containing phosphatase 1 (SHP-1) to immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and inhibits B-cell receptor (BCR)-induced Ca2+ signaling on normal B cells. CD22 interacts specifically with ligands carrying alpha2-6-linked sialic acids. As an inhibitory coreceptor of the B-cell receptor (BCR), CD22 plays a critical role in establishing signalling thresholds for B-cell activation. Like other coreceptors, the ability of CD22 to modulate B-cell signalling is critically dependent upon its proximity to the BCR, and this in turn is governed by the binding of its extracellular domain to alpha2,6-linked sialic acid ligands. However, genetic studies in mice reveal that some CD22 functions are regulated by ligand binding, whereas other functions are ligand-independent and may only require expression of an intact CD22 cytoplasmic domain at the B-cell surface. CD19 regulates CD22 phosphorylation by augmenting Lyn kinase activity, while CD22 inhibits CD19 phosphorylation via SHP-1.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
偶联 | Unconjugated |
其他可选修饰符 | FITC/PE |
可提供抗体种类 | 3 |
免疫原 | Recombinant Mouse CD22 Protein (TMPY-04083) |
抗原种属 | Mouse |
研究领域 | Cancer Drug Targets, ITIM/ITAM Immunoreceptors and Related Molecules |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容